Stay updated on Indoximod Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.

Latest updates to the Indoximod Combo in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMelanoma and the related topic MedlinePlus Genetics were removed from the Related Topics/MeSH section. This change is a minor metadata adjustment that does not alter the study details, eligibility criteria, or trial results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoChange DetectedThe page revision list now includes Revision: v3.3.2 added and Revision: v3.2.0 removed, indicating a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved a notice about a lapse in government funding and operating status. The page continues to display the study details, locations, and eligibility criteria.SummaryDifference0.4%

- Check49 days agoChange DetectedMedlinePlus Genetics related topics: Melanoma was added to the study page.SummaryDifference0.9%

- Check56 days agoChange DetectedAdded MedlinePlus Genetics topic: Melanoma. No deletions.SummaryDifference0.3%

- Check63 days agoChange Detected- Removed MedlinePlus Genetics topic on Melanoma, narrowing the page's content scope.SummaryDifference0.3%

Stay in the know with updates to Indoximod Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Indoximod Combo in Melanoma Clinical Trial page.